医用臭氧注射疗程对大鼠颞下颌关节骨关节炎及其疼痛作用的影响

doi:10.13591/j.cnki.kqyx.2024.05.008

Abstract

Abstract:

Objective To investigate the effect of medical ozone injection therapy on temporomandibular joint (TMJ) osteoarthritis and its pain in SD rats. Methods Fifity-four rats were randomly assigned according to a random number table into three groups: control group, model group, and medical ozone group, with 18 rats in each group. In the control group, only physiological saline was injected during modeling; in the model group, only sodium iodoacetate was injected for modeling; in the medical ozone group, after injecting sodium iodoacetate into the joint cavity for modeling for one week, medical ozone was then injected into the joint cavity for intervention at a frequency of once a week, totaling 5 times. One week (week 2 after modeling), 3 weeks (week 4 after modeling), and 5 weeks (week 6 after modeling) after medical ozone injections, 6 rats from each group were euthanized. Mechanical withdrawal threshold of rats in each group was assessed before euthanasia, and the expression levels of interleukin-1β (IL-1β) in joint fluid of rats in each group were measured after euthanasia. Gross observation and modified Mankin’s scoring were performed on TMJ cartilage of rats in each group after stained with Pelletier score and Safranin O-Fast Green. Results During the same time period, compared to the control group, the model group showed a significant decrease in the mechanical pain threshold of the TMJ in rats at 1 week, 3 weeks, and 5 weeks (P<0.01). The expression levels of IL-1β in the TMJ fluid increased (P<0.01), and the Pelletier score and modified Mankin’s score of TMJ cartilage increased (P<0.01). In comparison to the model group, the medical ozone group exhibited a significant increase in the mechanical pain threshold of the TMJ in rats after 3 weeks and 5 weeks of medical ozone injections (P<0.01). The expression levels of IL-1β in the TMJ fluid decreased (P<0.01), and the Pelletier score and modified Mankin’s score of TMJ cartilage decreased (P<0.01). However, there were no statistically significant difference in the measured parameters in the TMJ cavity after 1 week of medical ozone injection (P>0.05).Within the medical ozone group, compared to the 1-week treatment, the mechanical pain threshold of the TMJ increased (P<0.01) and the expression levels of IL-1β in the TMJ fluid decreased at 3 weeks and 5 weeks (P<0.01). However, there was no statistically significant difference in the Pelletier score and modified Mankin’s score of TMJ cartilage (P>0.05) between different treatment duration.Additionally, there were no statistically significant differences in the mechanical pain threshold of the TMJ, expression levels of IL-1β in the TMJ fluid, Pelletier score, and modified Mankin’s score of TMJ cartilage between the medical ozone group at 3 weeks and 5 weeks (P>0.05). Conclusion Medical ozone treatment for more than 3 weeks can improve temporomandibular joint osteoarthritis and its associated pain in rats.

Key words: temporomandibular joint, osteoarthritis, pain, medical ozone, treatment duration

CLC Number:

R782.63

LU Caixia, ZHANG Simin, Nigeayi·AIHEMAITI , LI Xueer, CHEN Zeyuan, Maimaitituxun·TUERDI . Effect of medical ozone injection therapy on temporomandibular joint osteoarthritis and its pain in rats[J]. Stomatology, 2024, 44(5): 362-368.

Figures/Tables 6

Fig.1

Fig.2

Fig.3

Tab.1

Fig.4

Tab.2

References 32

[1]	Ferrillo M, Giudice A, Marotta N, et al. Pain management and rehabilitation for central sensitization in temporomandibular disorders: A comprehensive review[J]. Int J Mol Sci, 2022, 23(20):12164.
[2]	Schmidt C, Ertel T, Arbogast M, et al. The diagnosis and treatment of rheumatoid and juvenile idiopathic arthritis of the temporomandibular joint[J]. Dtsch Arztebl Int, 2022, 119(4):47-54.
[3]	Luo P, Feng C, Jiang C, et al. IL-37b alleviates inflammation in the temporomandibular joint cartilage via IL-1R8 pathway[J]. Cell Prolif, 2019, 52(6):e12692.
[4]	Liu WJ, Sun YP, He YQ, et al. IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint[J]. Int J Mol Med, 2017, 39(2):317-326. doi: 10.3892/ijmm.2016.2832 pmid: 28000839
[5]	Lepetsos P, Papavassiliou KA, Papavassiliou AG. Redox and NF-κB signaling in osteoarthritis[J]. Free Radic Biol Med, 2019, 132: 90-100.
[6]	王文辉, 郭刚, 李长文, 等. 基于Wnt/β-catenin信号通路探讨青藤碱联合脉冲射频缓解SNL大鼠疼痛的作用机制[J]. 西部中医药, 2021, 34(4):22-27.
[7]	Al-Ani Z. Temporomandibular joint osteoarthrosis: A review of clinical aspects and management[J]. Prim Dent J, 2021, 10(1):132-140. doi: 10.1177/2050168420980977 pmid: 33722124
[8]	Matheus HR, Özdemir ŞD, Guastaldi FPS. Stem cell-based therapies for temporomandibular joint osteoarthritis and regeneration of cartilage/osteochondral defects: A systematic review of preclinical experiments[J]. Osteoarthritis Cartilage, 2022, 30(9):1174-1185.
[9]	Chęciński M, Sikora M, Chęcińska K, et al. The administration of hyaluronic acid into the temporomandibular joints’ cavities increases the mandible’s mobility: A systematic review and meta-analysis[J]. J Clin Med, 2022, 11(7):1901.
[10]	Bocci V. Ozone as Janus: This controversial gas can be either toxic or medically useful[J]. Mediators Inflamm, 2004, 13(1):3-11.
[11]	Ozcan S, Muz A, Yildiz Altun A, et al. Intradiscal ozone therapy for lumbar disc herniation[J]. Cell Mol Biol, 2018, 64(5):52-55.
[12]	Fernández-Cuadros ME, Albaladejo-Florín MJ, Álava-Rabasa S, et al. Compassionate use of rectal ozone (O₃) in severe COVID-19 pneumonia: Acase-control study[J]. SN Compr Clin Med, 2021, 3(5):1185-1199.
[13]	El Meligy OA, Elemam NM, TalaatI M. Ozone therapy in medicine and dentistry: A review of the literature[J]. Dent J, 2023, 11(8):187.
[14]	Bocci VA. Scientific and medical aspects of ozone therapy. State of the art[J]. Arch Med Res, 2006, 37(4):425-435. doi: 10.1016/j.arcmed.2005.08.006 pmid: 16624639
[15]	Re K, Gandhi J, Liang R, et al. Clinical utility of ozone therapy and hyperbaric oxygen therapy in degenerative disc disease[J]. Med Gas Res, 2023, 13(1):1-6. doi: 10.4103/2045-9912.351890 pmid: 35946215
[16]	张婉霞, 买斯吐热木·黑力力, 尼加提·努尔穆罕默德, 等. 医用臭氧对颞下颌关节骨关节炎大鼠髁突软骨作用研究[J]. 中国实用口腔科杂志, 2022, 15(2):203-208.
[17]	张婉霞, 尼加提·努尔穆罕默德, 买斯吐热木·黒力力, 等. 关节腔内注射医用臭氧治疗颞下颌关节骨关节炎模型大鼠的合适剂量[J]. 中国组织工程研究, 2022, 26(23):3700-3705.
[18]	Shen QX, Huang WY, Qiu YY, et al. Bergapten exerts a chondroprotective effect in temporomandibular joint osteoarthritis by combining intestinal flora alteration and reactive oxygen species reduction[J]. Biomed Pharmacother, 2023, 167: 115525.
[19]	Shen P, Jiao ZX, Zheng JS, et al. Injecting vascular endothelial growth factor into the temporomandibular joint induces osteoarthr-itis in mice[J]. Sci Rep, 2015, 5: 16244. doi: 10.1038/srep16244 pmid: 26531672
[20]	Kellesarian SV, Al-Kheraif AA, Vohra F, et al. Cytokine profile in the synovial fluid of patients with temporomandibular joint disorders: A systematic review[J]. Cytokine, 2016, 77: 98-106. doi: 10.1016/j.cyto.2015.11.005 pmid: 26556103
[21]	de Bont LG, Stegenga B. Pathology of temporomandibular joint internal derangement and osteoarthrosis[J]. Int J Oral Maxillofac Surg, 1993, 22(2):71-74.
[22]	Marks PH, Donaldson ML. Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee[J]. Arthroscopy, 2005, 21(11):1342-1347. doi: 10.1016/j.arthro.2005.08.034 pmid: 16325085
[23]	Woodell-May J, Matuska A, Oyster M, et al. Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes[J]. J Orthop Res, 2011, 29(9):1320-1326. doi: 10.1002/jor.21384 pmid: 21437966
[24]	Kuiper S, Joosten LA, Bendele AM, et al. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis[J]. Cytokine, 1998, 10(9):690-702. pmid: 9770330
[25]	Johnson CI, Argyle DJ, Clements DN. In vitro models for the study of osteoarthritis[J]. Vet J, 2016, 209: 40-49. doi: 10.1016/j.tvjl.2015.07.011 pmid: 26831151
[26]	杨萍萍, 席鹏, 王晶, 等. 关节腔臭氧浴联合物理疗法治疗颞下颌关节不可复性盘前移位的效果评价[J]. 中国口腔颌面外科杂志, 2021, 19(2):121-125.
[27]	史丽璞, 王旭, 郇稳. 医用臭氧对膝骨关节炎患者疼痛程度、关节功能及血清NO、SOD、MDA的影响[J]. 风湿病与关节炎, 2021, 10(2):11-14.
[28]	王权亮, 张雯. 功能训练结合医用臭氧关节腔注射治疗膝骨性关节炎的效果观察[J]. 中国民康医学, 2019, 31(1):47-50.
[29]	Sire AD, Marotta N, Ferrillo M, et al. Oxygen-ozone therapy for reducing pro-inflammatory cytokines serum levels in musculoskele-tal and temporomandibular disorders: A comprehensive review[J]. Int J Mol Sci, 2022, 23(5):2528.
[30]	Haghighat S, Oshaghi S. Effectiveness of ozone injection therapy in temporomandibular disorders[J]. Adv Biomed Res, 2020, 9: 73. doi: 10.4103/abr.abr_105_20 pmid: 33816392
[31]	姜鹏, 傅志俭. 医用臭氧治疗膝骨性关节炎相关机制的研究进展[J]. 中国疼痛医学杂志, 2015, 21(7):532-535.
[32]	Bocci V, Borrelli E, Travagli V, et al. The ozone paradox: Ozone is a strong oxidant as well as a medical drug[J]. Med Res Rev, 2009, 29(4):646-682. doi: 10.1002/med.20150 pmid: 19260079

组别	1周	3周	5周
对照组	0.00±0.00	0.00±0.00	0.17±0.41
模型组	1.33±0.52^**	2.50±0.55^**▲▲	3.00±0.71^**▲▲
医用臭氧组	1.17±0.41^**	1.33±0.52^**##	1.50±0.55^**##

组别	1周	3周	5周
空白组	0.17±0.41	0.17±0.41	0.33±0.52
模型组	5.67±0.82^**	8.83±0.75^**▲▲	9.40±0.89^**▲▲
医用臭氧组	5.17±0.75^**	5.50±1.05^**##	5.83±0.75^**##

Effect of medical ozone injection therapy on temporomandibular joint osteoarthritis and its pain in rats

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 6

References 32

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	TAO Xingxing, WANG Jizhou, CHEN Peiyao, MA Siwei. Risk assessment and analysis of degenerative joint diseases in patients with temporomandibular disorder diseases under diffe-rent joint disc states [J]. Stomatology, 2024, 44(4): 245-249.
[2]	FU Kaiyuan, LEI Jie. Update of the classification, diagnosis and management of temporomandibular disorders [J]. Stomatology, 2024, 44(1): 6-10.
[3]	WEI Lili, LI Bo, CHENG Yong. Advances in the clinical application of MRI in temporomandibular joint disorders [J]. Stomatology, 2024, 44(1): 11-15.
[4]	ZHU Songsong. Surgical correction of adult mandibular deficiency [J]. Stomatology, 2024, 44(1): 16-19.
[5]	TENG Yingxuan, FENG Jianying. Research progress of the relationship between rheumatoid arthritis and temporomandibular joint disorders [J]. Stomatology, 2023, 43(9): 861-864.
[6]	XIE Yuqing, ZHANG Yang, WANG Lei. Clinical efficacy evaluation of simultaneous root canal preparation combined with ultrasonic washing in root canal treatment of diabetic patients [J]. Stomatology, 2023, 43(8): 711-716.
[7]	WANG Bingjie,WANG Chen,ZHANG Jinglu,ZHOU Weina,ZHOU Yanli,CHEN Yinan,ZHAO Jing. Clinical efficacy of two methods for the treatment of acute temporomandibular joint anterior disc displacement without reduction [J]. Stomatology, 2023, 43(4): 334-337.
[8]	YANG Xia, YE Qingyuan, SONG Changlong, HOU Rui, YANG Yaowu, WEI Jianhua. Progress of research on diagnosis and treatment of the first bite syndrome [J]. Stomatology, 2023, 43(2): 188-192.
[9]	QIAN Min, WU Mengjie. Review of MRI-based three-dimensional model reconstruction of temporomandibular joint [J]. Stomatology, 2023, 43(10): 930-934.
[10]	SHEN Yiyang, FENG Xiaoyan, ZHANG Chenxing, LI Juan, LIN Jun. Digital multidisciplinary treatment of an adult patient with high-angle skeletal Class Ⅱ malocclusion and obstructive sleep apnea hypopnea syndrome [J]. Stomatology, 2022, 42(9): 824-830.
[11]	HE Jiajia, ZHANG Ping, ZHOU Weina, JIANG Hongbing. Avagacestat inhibits osteoclast formation and attenuates bone destruction in osteoarthritis [J]. Stomatology, 2022, 42(9): 774-780.
[12]	GAO Lei, JIANG Yinhua. Research progress of intra-articular pressure of temporomandibular joint [J]. Stomatology, 2022, 42(7): 668-672.
[13]	JIN Chunxiao, YANG Lin, LIU Yang, LI Xiaojing, YU Lixia, GAO Shanshan. Relationship between temporomandibular joint disorder and body posture [J]. Stomatology, 2022, 42(4): 368-372.
[14]	LI Quanli, CAO Ying, WU Guomin, LIU Xingzi, HE Xiaoxue. A fixed occlusal rehabilitation protocol for severely worn dentition [J]. Stomatology, 2022, 42(12): 1080-1085.
[15]	GU Jiaona, JIAO Boqiang, LI Zhiyong. Progress of etiological research on temporomandibular joint anterior disc displacement [J]. Stomatology, 2022, 42(10): 942-945.